Page 4 - Biological Sample News Today

Kintor Pharmaceutical has dosed the first participant in China in its Phase III trial of proxalutamide to treat Covid-19 outpatients.

Middle East & Africa witnessed a 17.1% drops in IT hiring activity in the pharma industry in December 2021, according to GlobalData’s Job Analytics index

BioLineRx has completed enrolment in Phase I/IIa trial of its intratumoural cancer vaccine, AGI-134, to treat solid tumour patients.

Sciwind Biosciences has commenced participant dosing in Phase IIb trial of GLP-1 drug candidate, XW003, in individuals with obesity.